These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29859986)

  • 21. Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.
    Janssen R; Kruisselbrink A; Hoogteijling L; Lamb JR; Young DB; Thole JE
    Immunology; 2001 Apr; 102(4):441-9. PubMed ID: 11328378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a universal influenza virus vaccine: Some cytokines may fulfill the request.
    Taheri M; Nemattalab M; Mahjoob M; Hasan-Alizadeh E; Zamani N; Nikokar I; Evazalipour M; Soltani Tehrani B; Shenagari M
    Cytokine; 2021 Dec; 148():155703. PubMed ID: 34555604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
    Even-Or O; Samira S; Rochlin E; Balasingam S; Mann AJ; Lambkin-Williams R; Spira J; Goldwaser I; Ellis R; Barenholz Y
    Vaccine; 2010 Sep; 28(39):6527-41. PubMed ID: 20412874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
    Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
    J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses to antigens of in vitro reared Echinococcus granulosus adult worms in Balb/c mice.
    Rahimi HR; Sarkari B; Mohammadzadeh T; Sadjjadi SM
    Iran J Immunol; 2011 Dec; 8(4):236-43. PubMed ID: 22201621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis.
    Yoon IS; Park H; Kwak HW; Woo Jung Y; Nam JH
    Vaccine; 2017 Aug; 35(36):4687-4694. PubMed ID: 28760610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice.
    Lv J; Zhang YY; Lu X; Zhang H; Wei L; Gao J; Hu B; Hu WW; Hu DZ; Jia N; Feng X
    Biologicals; 2017 Mar; 46():130-138. PubMed ID: 28215694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell response to seasonal influenza vaccine in mice is amenable to pharmacological modulation through β-adrenoceptor.
    Bufan B; Arsenović-Ranin N; Živković I; Petrović R; Leposavić G
    Life Sci; 2022 Jul; 301():120617. PubMed ID: 35533760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model.
    Babiuk S; Skowronski DM; De Serres G; HayGlass K; Brunham RC; Babiuk L
    J Med Virol; 2004 Jan; 72(1):138-42. PubMed ID: 14635022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes.
    Rosenkrands I; Vingsbo-Lundberg C; Bundgaard TJ; Lindenstrøm T; Enouf V; van der Werf S; Andersen P; Agger EM
    Vaccine; 2011 Aug; 29(37):6283-91. PubMed ID: 21722683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant.
    Park SA; Song ES; Cho YJ; Ahn BY; Ha SH; Seong BL; Lee KH; Lee NG
    Microbiol Immunol; 2007; 51(11):1099-107. PubMed ID: 18037787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
    Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
    Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mouse chorionic gonadotropin beta-subunit-like (muCG beta l) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CG beta (rmCG beta).
    Shi SQ; Peng JP; Xu L; Yang Y; Chen Y
    J Gene Med; 2005 Jan; 7(1):87-96. PubMed ID: 15517553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective neutralizing influenza antibody response in the absence of T follicular helper cells.
    Miyauchi K; Sugimoto-Ishige A; Harada Y; Adachi Y; Usami Y; Kaji T; Inoue K; Hasegawa H; Watanabe T; Hijikata A; Fukuyama S; Maemura T; Okada-Hatakeyama M; Ohara O; Kawaoka Y; Takahashi Y; Takemori T; Kubo M
    Nat Immunol; 2016 Dec; 17(12):1447-1458. PubMed ID: 27798619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice.
    Christy AJ; Dharman K; Dhandapaani G; Palaniyandi K; Gupta UD; Gupta P; Ignacimuthu S; Narayanan S
    Vaccine; 2012 Feb; 30(7):1364-70. PubMed ID: 22200502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.
    Ou H; Yao H; Yao W; Wu N; Wu X; Han C; Cheng L; Chen K; Chen H; Li L
    Vaccine; 2016 Apr; 34(20):2362-70. PubMed ID: 27013436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.